Universal-Beteiligungs- und Servicegesellschaft
SRPT icon

Universal-Beteiligungs- und Servicegesellschaft’s Sarepta Therapeutics SRPT Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Buy
61,256
+2,890
+5% +$54.7K ﹤0.01% 1529
2026
Q1 		$1.27M Hold
58,366
– – ﹤0.01% 1426
2025
Q4 		$1.25M Buy
58,366
+12,948
+29% +$273K ﹤0.01% 1416
2025
Q3 		$875K Buy
+45,418
New +$810K ﹤0.01% 1594
2025
Q2 		– Sell
-27,607
Closed -$1.76M – 2103
2025
Q1 		$1.76M Buy
+27,607
New +$2.91M ﹤0.01% 1258

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's SRPT Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Sarepta Therapeutics (SRPT) stake by 5% in Q2 2026, buying an estimated $54.7K and bringing the position to 61,256 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1529.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in SRPT in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.76M in Q1 2025. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 61,256 shares of Sarepta Therapeutics worth $1.1M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 2,890 Sarepta Therapeutics shares in Q2 2026, an estimated $54.7K.
  • Sarepta Therapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1529 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Sarepta Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Sarepta Therapeutics position peaked at $1.76M in Q1 2025.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.